These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 38513325)
21. 18F-labeled styrylpyridines as PET agents for amyloid plaque imaging. Zhang W; Kung MP; Oya S; Hou C; Kung HF Nucl Med Biol; 2007 Jan; 34(1):89-97. PubMed ID: 17210465 [TBL] [Abstract][Full Text] [Related]
22. Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers. Constantinescu CC; Tresse C; Zheng M; Gouasmat A; Carroll VM; Mistico L; Alagille D; Sandiego CM; Papin C; Marek K; Seibyl JP; Tamagnan GD; Barret O Mol Imaging Biol; 2019 Jun; 21(3):509-518. PubMed ID: 30084043 [TBL] [Abstract][Full Text] [Related]
23. Radiosynthesis and in vivo evaluation of a new positron emission tomography radiotracer targeting bromodomain and extra-terminal domain (BET) family proteins. Bai P; Lu X; Lan Y; Chen Z; Patnaik D; Fiedler S; Striar R; Haggarty SJ; Wang C Nucl Med Biol; 2020; 84-85():96-101. PubMed ID: 32320910 [TBL] [Abstract][Full Text] [Related]
24. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5. Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101 [TBL] [Abstract][Full Text] [Related]
25. Preclinical Evaluation and Quantification of Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720 [TBL] [Abstract][Full Text] [Related]
26. Radiochemistry for positron emission tomography. Rong J; Haider A; Jeppesen TE; Josephson L; Liang SH Nat Commun; 2023 Jun; 14(1):3257. PubMed ID: 37277339 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of two new candidate high-affinity full agonist PET radioligands for imaging 5-HT Lindberg A; Lu S; Nag S; Schou M; Liow JS; Zoghbi SS; Frankland MP; Gladding RL; Morse CL; Takano A; Amini N; Elmore CS; Lee YS; Innis RB; Halldin C; Pike VW Nucl Med Biol; 2019 Mar; 70():1-13. PubMed ID: 30811975 [TBL] [Abstract][Full Text] [Related]
29. Impact of structural alterations on the radiopharmacological profile of Tietz O; Marshall A; Bergman C; Wuest M; Wuest F Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and Preclinical Evaluation of the First Carbon-11 Labeled PET Tracers Targeting Substance P Pekošak A; Bulc JŽ; Korat Š; Schuit RC; Kooijman E; Vos R; Rongen M; Verlaan M; Takkenkamp K; Beaino W; Poot AJ; Windhorst AD Mol Pharm; 2018 Nov; 15(11):4872-4883. PubMed ID: 30335399 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor. Mathews WB; Murugesan N; Xia J; Scheffel U; Hilton J; Ravert HT; Dannals RF; Szabo Z J Nucl Med; 2008 Sep; 49(9):1529-36. PubMed ID: 18703610 [TBL] [Abstract][Full Text] [Related]
32. Brain penetrant small molecule (18)F-GnRH receptor (GnRH-R) antagonists: Synthesis and preliminary positron emission tomography imaging in rats. Olberg DE; Bauer N; Andressen KW; Hjørnevik T; Cumming P; Levy FO; Klaveness J; Haraldsen I; Sutcliffe JL Nucl Med Biol; 2016 Aug; 43(8):478-89. PubMed ID: 27236283 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of [(11)C]PyrATP-1, a novel radiotracer for PET imaging of glycogen synthase kinase-3β (GSK-3β). Cole EL; Shao X; Sherman P; Quesada C; Fawaz MV; Desmond TJ; Scott PJ Nucl Med Biol; 2014 Jul; 41(6):507-12. PubMed ID: 24768148 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and Preclinical Evaluation of Fluorinated 5-Azaindoles as CB2 PET Radioligands. Kallinen A; Mardon K; Lane S; Montgomery AP; Bhalla R; Stimson DHR; Ahamed M; Cowin GJ; Hibbs D; Werry EL; Fulton R; Connor M; Kassiou M ACS Chem Neurosci; 2023 Aug; 14(16):2902-2921. PubMed ID: 37499194 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and Preclinical Positron Emission Tomography Imaging of the p38 MAPK Inhibitor [ Chassé M; Vasdev N ACS Chem Neurosci; 2023 Jun; 14(11):2193-2200. PubMed ID: 37186961 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of a novel series of fluorine-18-labeled imidazobenzodiazepines as potential new positron emission tomography radioligands for the GABAA receptor. Jackson A; Battle MR; O'Shea DM; Chau WF; Gaeta A; Brown SL; Ewan AL; Jones CL; Jones PA; Woodcraft JL; Bouvet DR; Guilbert BB; Trigg W Nucl Med Biol; 2014 Feb; 41(2):196-202. PubMed ID: 24480268 [TBL] [Abstract][Full Text] [Related]